Horizon Technology Finance Corporation ("Horizon") (the "Company"), an affiliate of Monroe Capital, today announced it has provided a $50 million venture loan facility to Pelthos Therapeutics Inc.
In addition to Mixon, many reviewers say this serum has made their skin smoother, helped improve acne, reduced the appearance ...
It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback